Biotech Firm SciSparc Takes Bold Step with 21:1 Share Consolidation

Rhea-AI Filing Summary

SciSparc Ltd has announced a significant corporate action with a 1-for-21 reverse share split as reported in their Form 6-K filing dated June 28, 2025. This strategic move will consolidate every 21 existing shares into 1 new share.

Key filing details:

• Filing incorporates by reference into multiple registration statements, including Form F-3 (6 filings) and Form S-8 (3 filings)
• Document signed by Oz Adler, who serves as both Chief Executive Officer and Chief Financial Officer
• Company maintains its principal executive offices in Tel Aviv, Israel
• Confirms status as a Form 20-F filer for annual reports

The reverse split announcement suggests a potential strategic effort to meet minimum share price requirements for continued exchange listing or improve the stock's marketability to institutional investors.

Positive

• None.

Negative

• Company implementing a significant 1-for-21 reverse stock split, typically indicating serious share price challenges and potential delisting risk

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of June 2025 (Report No. 2)

 

Commission file number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

 

CONTENTS

 

On June 24, 2025, SciSparc Ltd. (the “Company”) issued a press release titled “SciSparc Announces 1-for-21 Reverse Share Split” a copy of which is furnished as Exhibit 99.1 to this Form 6-K.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437, 333-225773 and 333-286791)  filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

ExhibitNo.	 	 
99.1	 	Press release issued by SciSparc Ltd., dated June 24, 2025, titled “SciSparc Announces 1-for-21 Reverse Share Split”.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 	SciSparc Ltd.
 	 	 
Date: June 24, 2025	By:	/s/ Oz Adler 
 	Name: 	Oz Adler
 	Title:	Chief Executive Officer and Chief Financial Officer

 

3

 

FAQ

What is SPRC's latest reverse stock split ratio announced in June 2025?

SciSparc Ltd. (SPRC) announced a 1-for-21 reverse share split on June 24, 2025, as disclosed in their Form 6-K filing.

When will SPRC's reverse stock split take effect?

The exact effective date of SPRC's 1-for-21 reverse stock split is not specified in the Form 6-K filing from June 28, 2025. The announcement was made on June 24, 2025.

Who is the current CEO of SPRC as of June 2025?

According to the Form 6-K filing, Oz Adler serves as both Chief Executive Officer and Chief Financial Officer of SciSparc Ltd. (SPRC), as confirmed by his signature dated June 24, 2025.

Which SEC registration statements are affected by SPRC's June 2025 Form 6-K?

This Form 6-K is incorporated into SPRC's Form F-3 registration statements (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, and 333-255408) and Form S-8 registration statements (File Nos. 333-278437, 333-225773, and 333-286791).